Search

everythinglearnresearchcommunity

for

Search:↓

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The nutritional supplement improved hair quality and reduced hair loss.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair loss requires customized treatments based on its various causes and types.

Researchers found new hair and nail genes, how hair reacts to UV, differences in white and pigmented hair growth, nerve changes in alopecia, treatments for baldness and alopecia, a toenail condition linked to a genetic disorder, and that nail fungus is more common in people with psoriasis.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.